StreetInsider.com News Articles

Form SCHEDULE 13G/A VivoSim Labs, INC. Filed by: Esousa Group Holdings LLC

Mon, 17 Aug 2026 21:00:00 -0400

si-local-file:///var/storage/secattach/20260817/26939365.html

Form SCHEDULE 13G/A VivoSim Labs, INC. Filed by: Esousa Group Holdings LLC

Mon, 17 Aug 2026 21:00:00 -0400

si-local-file:///var/storage/secattach/20260817/26939365.html

Form PRER14A VivoSim Labs, INC.

Thu, 13 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26922529.html

Form PRER14A VivoSim Labs, INC.

Thu, 13 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26922529.html

Form 10-Q VivoSim Labs, INC. For: Jun 30

Wed, 12 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26912823.html

Form 10-Q VivoSim Labs, INC. For: Jun 30

Wed, 12 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26912823.html

Form EFFECT VivoSim Labs, INC.

Tue, 11 Aug 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260811/26900698.html

Form EFFECT VivoSim Labs, INC.

Tue, 11 Aug 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260811/26900698.html

Form PRE 14A VivoSim Labs, INC. For: Sep 30

Mon, 10 Aug 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260810/26895333.html

Form PRE 14A VivoSim Labs, INC. For: Sep 30

Mon, 10 Aug 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260810/26895333.html

VivoSim Labs regains Nasdaq compliance after cash infusion

Thu, 06 Aug 2026 08:05:44 -0400

VivoSim Labs, Inc. (Nasdaq: VIVS) announced it received notice from Nasdaq on August 4, 2026, that the company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2.5 million.

The compliance was achieved following several financial events that occurred after the close of its fiscal year ended March 31, 2026. The company received a $5.0 million milestone payment from Eli Lilly and Company, along with $1.0 million in cash released from escrow on July 22, 2026, both tied to the company's prior sale of its FXR program to Eli Lilly.

On July 17, 2026, VivoSim completed

Form 8-K VivoSim Labs, INC. For: Aug 06

Thu, 06 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260806/26879366.html

Form 8-K VivoSim Labs, INC. For: Aug 06

Thu, 06 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260806/26879366.html

VivoSim Provides Financial and Listing Compliance Update

Thu, 06 Aug 2026 08:05:00 -0400

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced that on August 4, 2026, we received notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1) which requires registrants to maintain a minimum stockholders’ equity of $2.5M.

Subsequent to the filing of its recent Annual Report on Form 10-K for the fiscal year ended March 31,

VivoSim Provides Financial and Listing Compliance Update

Thu, 06 Aug 2026 08:05:00 -0400

Subsequent to the filing of its recent Annual Report on Form 10-K for the fiscal year ended March 31,

Form S-1 VivoSim Labs, INC.

Fri, 31 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260731/26850938.html

Form S-1 VivoSim Labs, INC.

Fri, 31 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260731/26850938.html

Form 8-K VivoSim Labs, INC. For: Jul 30

Thu, 30 Jul 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260730/26843738.html

Form 8-K VivoSim Labs, INC. For: Jul 30

Thu, 30 Jul 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260730/26843738.html

Form 8-K VivoSim Labs, INC. For: Jul 20

Fri, 24 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260724/26813591.html

Form 8-K VivoSim Labs, INC. For: Jul 20

Fri, 24 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260724/26813591.html

VivoSim makes first commercial sales in China for NAMkind testing

Tue, 21 Jul 2026 08:05:32 -0400

VivoSim Labs, Inc. (Nasdaq: VIVS) announced its first commercial sales in China, securing two initial contracts through its local distributor, Tekon, according to a company statement.

The two engagements are with a Shanghai-based oncology biotech and a Chengdu-based pharmaceutical company. Both orders cover gastrointestinal toxicology screening and NAMkind™ GI efficacy profiling for drug candidates in oncology and other disease areas. The company said the contracts represent a meaningful share of its total contracted revenue to date.

VivoSim's NAMkind™ platform uses 3D human organoid models of the liver and intestine, built from primary human donor cells and paired with proprietary AI. The company

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

Tue, 21 Jul 2026 08:05:00 -0400

Initial customer wins bring VivoSim’s human-relevant liver and GI testing to the world’s second-largest pharmaceutical market

SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in China, opening a significant new market for its NAMkind™ testing services. VivoSim delivers both toxicology and efficacy testing built on its 3D human tissue models of the liver and gastrointestinal (GI) tract. The two initial engagements, with a leading Shanghai-based oncology biotech and a large Chengdu-based pharmaceutical

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

Tue, 21 Jul 2026 08:05:00 -0400

Initial customer wins bring VivoSim’s human-relevant liver and GI testing to the world’s second-largest pharmaceutical market

Form 8-K VivoSim Labs, INC. For: Jul 16

Fri, 17 Jul 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260717/26782330.html